R Discovery: Fueling Biotech's Future, From Discovery to Therapy

R Discovery is a unique venture capital firm with a dual focus on Japan and the US, dedicated to transforming groundbreaking early-stage biotech innovations into life-changing therapies. They actively seek out and invest in promising technologies and companies, driving the future of therapeutic development.

What Makes R Discovery Stand Out?

Cross-Border Expertise: R Discovery leverages an extensive global network to identify exceptional early-stage biotech discoveries, bridging the gap between Japan and the US.
Dedicated Innovation Incubator: Through their in-house incubator, they provide hands-on support to nurture and scale companies founded on discoveries from top Japanese academic institutions.
Strategic Investment Focus: The R Discovery Fund is specifically designed to foster innovation originating in Japan, providing crucial capital and strategic guidance.
Value-Added Partnerships: They are known for connecting their portfolio companies with valuable partnership opportunities, particularly with major pharmaceutical players.
Translational and Financial Acumen: R Discoverys team brings a wealth of expertise in finance, biotechnology, and translational science, offering more than just funding.